Bismuth Subcitrate Potassium, Metronidazole And Tetracycline Hydrochloride Capsule
Product Images NDC 49884-151

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bismuth Subcitrate Potassium, Metronidazole And Tetracycline Hydrochloride (NDC 49884-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Metronidazole-stru-formula (Bis Subcitrate Pot Met Tet 1)

Chemical structure diagram of the active ingredient metronidazole, showing its molecular components including a nitro group, methyl group, hydroxyl group, and nitrogen-containing ring. The molecular weight is indicated as 171.2.*

FDA Label Image

Tetracycline-stru-formula (Bis Subcitrate Pot Met Tet 2)

Chemical structure diagram of the active ingredient tetracycline hydrochloride, showing its molecular framework with various functional groups such as hydroxyl (OH), amine (NH2), and methyl (CH3). The molecular weight is indicated as 480.90.*

FDA Label Image

Blister_foil_-_par.jpg (Bis Subcitrate Pot Met Tet 3)

Label for Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride Capsules, 140 mg/125 mg/125 mg, in a blister card format. Each label states 3 capsules per blister with dosage instructions and manufacturer details for Par Health USA, Rochester, MI. The label includes barcode, NDC 49884-151-24, and space for lot and expiration date.*

FDA Label Image

Blister_carton_-_par.jpg (Bis Subcitrate Pot Met Tet 4)

Packaging label for Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride Capsules 140 mg / 125 mg / 125 mg, 10 Day Therapy PAK. The label shows a 10-day therapy pack containing 120 capsules in 10 blister cards made by Par Health USA, LLC. The label includes dosage instructions and storage information, with capsules supplied as white opaque capsules marked with "440" and "PAR." Manufactured in India, the product is intended for oral use and includes detailed drug information and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.